Source: Eur Respir J 2015; 46: 207-218
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Lantuejoul Sylvie, Rouquette Isabelle, Blons Hélène, Le Stang Nolwenn, Ilie Marius, Begueret Hugues, Grégoire Valerie, Hofman Paul, Gros Audrey, Garcia Stephane, Monhoven Nathalie, Devouassoux-Shisheboran Mojgan, Mansuet-Lupo Audrey, Thivolet Françoise, Antoine Martine, Vignaud Jean-Michel, Penault-Llorca Frederique, Galateau-Sallé Françoise, McLeer-Florin Anne. French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas. Eur Respir J 2015; 46: 207-218

Member's Comments

No comment yet.

Related content which might interest you: Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study Source: Eur Respir J, 51 (3) 1701467; 10.1183/13993003.01467-2017 Year: 2018 Survival outcomes of patients diagnosed with lung adenocarcinoma with ALK gene rearrangement Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Prevalence of ALK translocations in a large cohort of non-small cell cancer patients and quality of hybridization by sampling method. Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Evaluation of gene mutation status and metastasis in lung adenocarcinoma: a multicentric prospective study in Turkey Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Asbestos-related lung cancers are rarely associated with ALK, ROS1 and RET rearrangements Source: Eur Respir J, 51 (3) 1702605; 10.1183/13993003.02605-2017 Year: 2018 Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010 Mutational status of advanced lung adenocarcinoma in a Portuguese cohort Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology Year: 2019 Population-based study of synchronous primary malignant lung tumours Source: Breathe 2008; 4: 368 Year: 2008 Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study Source: Eur Respir J, 50 (6) 1701493; 10.1183/13993003.01493-2017 Year: 2017 The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Natural course of asymptomatic malignant pleural effusion in non-small-cell lung cancer patients: a multicenter retrospective study Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020 Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement: Analysis of two cases and literature review Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Cytological samples for the study of EGFR, KRAS and ALK mutations in non-small cell lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis Source: Eur Respir J 2008; 31: 854-859 Year: 2008 The diagnostic puzzle of ALK rearrangement in lung cancer. A novel intron related abnormality Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Clinical and molecular features of V600E and non-V600E BRAF mutations in NSCLC – a retrospective monocentric observational study Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020 Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens Source: Eur Respir Rev, 26 (144) 170007; 10.1183/16000617.0007-2017 Year: 2017 Expression of c-met in malignant pleural mesothelioma; an immunohistochemical study Source: Annual Congress 2007 - Inorganic dust "old timers and new kids on the block" Year: 2007 The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013